Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
P Ding, H Guo, C Sun, S Chen, P Yang, Y Tian… - Frontiers in …, 2022 - frontiersin.org
Background It is well known that sarcopenia is a common risk factor in patients with
gastrointestinal tumours, which may negatively affect the clinical outcome and prognosis …
gastrointestinal tumours, which may negatively affect the clinical outcome and prognosis …
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
J Sun, H Yang, W Cai, J Zheng, N Shen, X Yang… - BMC …, 2022 - Springer
Background Sarcopenia is an age-related syndrome that may have negative impact on
surgical outcomes and long-term survival of patients with gastric cancer. Serum …
surgical outcomes and long-term survival of patients with gastric cancer. Serum …
Sarcopenia as a novel prognostic factor in the patients of primary localized gastrointestinal stromal tumor
H Song, X Xiao, G Liu, J Zhou - BMC cancer, 2022 - Springer
Background Sarcopenia predicts poor prognosis of a variety of gastrointestinal
malignancies. However, there is a lack of study on the association between skeletal muscle …
malignancies. However, there is a lack of study on the association between skeletal muscle …
Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
H Liu, J Wang, S Tan, Z Zhang, M Yan, J Han… - Journal of translational …, 2023 - Springer
Objective This study aimed to develop a simplified diagnostic tool for assessing sarcopenia
and myosteatosis in gastrointestinal cancer patients, focusing on the creatinine to cystatin C …
and myosteatosis in gastrointestinal cancer patients, focusing on the creatinine to cystatin C …
A new diagnostic index for sarcopenia and its association with short‐term postoperative complications in patients undergoing surgery for colorectal cancer
J Yang, T Zhang, D Feng, X Dai, T Lv… - Colorectal …, 2019 - Wiley Online Library
Aim Sarcopenia is a robust prognostic indicator of outcomes after surgery for colorectal
cancer (CRC). However, there are no serum markers routinely available for estimating …
cancer (CRC). However, there are no serum markers routinely available for estimating …
Relationship between the creatinine/cystatin C ratio and muscle mass measured by CT-scan in cancer patients
C Tlemsani, JP Durand, B Raynard, MP Revel… - Clinical nutrition …, 2022 - Elsevier
Background Sarcopenia is observed in about 50% of cancer patients. Cancer-related
sarcopenia negatively affects survival and is a predictive factor of anticancer drug toxicity …
sarcopenia negatively affects survival and is a predictive factor of anticancer drug toxicity …
A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer
X Fu, Z Tian, S Wen, H Sun, S Thapa, H Xiong, H Liu… - Nutrition, 2021 - Elsevier
Objectives Sarcopenia is a well-known risk factor for inferior cancer outcomes, but the
identification of patients at risk remains challenging. A new sarcopenia index (SI), defined as …
identification of patients at risk remains challenging. A new sarcopenia index (SI), defined as …
Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
C Zheng, E Wang, JS Li, K Xie, C Luo, QY Ge, LW Hu… - BMC geriatrics, 2022 - Springer
Background & aims Sarcopenia is associated with poor clinical outcomes of patients who
underwent esophagectomy. The current diagnostic criteria for sarcopenia are complex and …
underwent esophagectomy. The current diagnostic criteria for sarcopenia are complex and …
CT-based assessment of sarcopenia for differentiating wild-type from mutant-type gastrointestinal stromal tumor
X Yi, G Zhou, Y Fu, J Wu, C Chen, H Zai, Q He… - Scientific Reports, 2023 - nature.com
Non-invasive prediction for KIT/PDGFRA status in GIST is a challenging problem. This study
aims to evaluate whether CT based sarcopenia could differentiate KIT/PDGFRA wild-type …
aims to evaluate whether CT based sarcopenia could differentiate KIT/PDGFRA wild-type …
CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis
H Su, J Ruan, T Chen, E Lin, L Shi - Cancer Imaging, 2019 - Springer
Background The impact of sarcopenia on the outcome of gastrointestinal (GI) oncological
patients is still controversial. We aim to discuss the prevalence of sarcopenia and its relation …
patients is still controversial. We aim to discuss the prevalence of sarcopenia and its relation …